Ear Acupuncture for Acute Sore Throat.

This study is currently recruiting participants.
Verified April 2012 by Mike O'Callaghan Federal Hospital
Sponsor:
Information provided by (Responsible Party):
Mike O'Callaghan Federal Hospital
ClinicalTrials.gov Identifier:
NCT01302769
First received: February 18, 2011
Last updated: April 19, 2012
Last verified: April 2012
  Purpose

The purpose of this study is to compare ear acupuncture plus standard of care versus standard therapy (anti-inflammatory medications) in the reduction of pain, reduction in oral anti inflammatory medication use, hours lost from work in acute sore throat.


Condition Intervention
Acute Sore Throat
Device: Standard treatment plus ear acupuncture

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Ear Acupuncture for Acute Sore Throat. A Randomized Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Mike O'Callaghan Federal Hospital:

Primary Outcome Measures:
  • Reduction in Pain [ Time Frame: 5 months ] [ Designated as safety issue: No ]
    Subjects will be randomized to recieve either standard treatment alone or standard treatment plus ear acupuncture. Subjects will be asked 15 minutes after their treatment to assess their pain on a scale of 0-10. After the subject has left the clinic, phone calls will be made at 6 hours, 24 hours and 48 hours to assess their pain level, ask about their missed hours from work, and ask the number of doses of ibuprofen taken. Subjects who report back after 48 hours with unimproved sore throat will be instructed to make a same day follow up with the clinic.


Estimated Enrollment: 65
Study Start Date: October 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Standard treatment plus ear acupuncture
    Standard treatment plus ear acupuncture
    Other Name: Sedatelec ASP Original Gold needles
  Hide Detailed Description

Detailed Description:

Subjects (MOFH personnel and DoD beneficiaries) that are 18 years or older with a chief complaint of acute sore throat will be booked for appointments in the Acute Sore Throat Clinic. At the time of check-in the subject will be screened by the technician and will be asked the screening questions for exclusion criteria (See attached instrument). If the subject is eligible for inclusion into the study, the Informed Consent process will be performed and documented by someone on the study staff. The PI will have the AI or Study staffs recruit their patients to prevent any misconception of coercion. The inclusion/exclusion criteria will be verified in Armed Forces Health Longitudinal Technology Application (AHLTA). The investigator will evaluate the subject and further determine any further exclusion criteria based on exam. The subject will have adequate time to ask questions concerning the study and will sign the Informed Consent Document and HIPAA Authorization Form prior to any study-related procedures being performed. The subject will get a throat culture and will receive standard pain treatment defined as 600 milligrams (mg) of oral ibuprofen every 6-8 hours as needed as standard of care. If throat culture is positive, patients will be notified and referred to their Primary Care Manager to be prescribed standard of care antibiotics. These subjects will then be randomized into two groups using a random number generator via block randomization by the Research Coordinator:

Group 1: Standard treatment alone Group 2: Standard treatment plus ear acupuncture

These subjects will then be given treatment according to their randomization group. The ear will be cleansed with an alcohol swab prior to ear acupuncture. Subjects will be asked 15 minutes after their treatment to assess their pain on a scale of 0-10 (with 10 being the worst pain). After the subject has left the clinic, phone calls will be made at 6 hours, 24 hours and 48 hours to assess their pain level, ask about their missed hours from work, and ask the number of doses of ibuprofen taken (see attached telephone data collection tool). Subjects who report back after 48 hours with unimproved sore throat will be instructed to make a same day follow up with the clinic.

Ear acupuncture utilizes up to 10 needles (see figure 6). If at any point the subject decides not to continue with the placing of the needles, the acupuncture will cease and the number of points will be documented. The ear Acupuncture points on the right ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The ear Acupuncture points on the left ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero (see figures 1-5).

Subject's participation in this study is completed after 48 hours.

Patients in group 2 who are receiving ear Acupuncture will be instructed to have no heavy meals, excessive hot or cold foods, heavy exercise or intercourse and no alcohol for 24 hours. Ear needles will fall out on their own within 6 days.

All investigators are trained in Battlefield Acupuncture and credentialed by the MOFH Credentials committee to perform Battlefield Acupuncture.

We anticipate that the ear acupuncture will improve the reduction in pain by 2 points on a 10 point scale. (0-10 point scale-10 being the worst pain)

The risks associated with the use of ear acupuncture needles include: pain, bleeding, infection (very rare) and flare of signs and symptoms. In the event the acupuncture needles do not fall out within 6 days, patients will be instructed to come in and have them removed by one of the Investigators. In this study we are using Sedatelec ASP Original Gold needles. These acupuncture needles are sterile, gold plated semi permanent ear acupuncture needles for single use. (see figure 6) If at any time during the study, the subject decides to withdraw from the study, they can come in and have the ear acupuncture needles removed by one of the Investigators. If a subject becomes pregnant during the study, they will be withdrawn from the study and the acupuncture needles will be removed. If patients are withdrawn from the study, they will have the option to either have the acupuncture needles removed by one of the investigators or allow them to fall out on their own.

Patients must agree to take precautions to prevent pregnancy during the course of this study. The only completely reliable methods of birth control are total abstinence or surgical removal of the uterus. Other methods, such as the use of condoms, a diaphragm or cervical cap, birth control pills, IUD, or sperm killing products are not totally effective in preventing pregnancy. Also, women who are breastfeeding may not participate in this study.

The Food and Drug Administration (FDA) regulates acupuncture needles as a class II medical device because they are intended for use in the cure, mitigation, treatment, or prevention of disease in man or are intended to affect the structure or function of the body of man. The FDA regulates the acupuncture needles (see 21 CFR 880.5580), but not the practice of acupuncture itself. The needles being used are Sedatelec ASP Original Gold needles, which are approved by the FDA for use in acupuncture and will be used in accordance with their FDA approved labeling.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion:

  • Tricare Insurance Beneficiary (military insurance) receiving care at Nellis AFB
  • Male and female subjects (MOFH personnel and DoD beneficiaries), 18 years or older, with upper respiratory complaints and their primary symptom being acute sore throat.
  • Minimum pain score of 5 points on a 0-10 point scale (with 10 being the worst pain)

Exclusion:

  • History of significant gastrointestinal bleed
  • Previous documented history of stage 2 kidney disease or worse
  • Pregnancy
  • History of gastric bypass surgery
  • Known Peritonsillar abscess (PTA)
  • Throat, mouth or esophageal cancer
  • Chronic oral steroids use
  • Absence of one or more ears
  • Active cellulitis of ear
  • Ear anatomy precluding identification of acupuncture landmarks
  • Non-English speaking
  • Use of Hearing Aids
  • Allergy to Ibuprofen
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01302769

Contacts
Contact: Jennie Moss, R.N. 7026532756 jennie.moss@nellis.af.mil
Contact: David Moss, M.D. 7026532756 david.moss@nellis.af.mil

Locations
United States, Nevada
Mike O'Callaghan Federal Hosptial Recruiting
Nellis AFB, Nevada, United States, 89191
Contact: Jennie Moss, R.N.     7026532756     jennie.moss@nellis.af.mil    
Contact: Jill M Teixeira, MBA/HCM, CCRP, CCRC     7026532756     jill.teixeira@nellis.af.mil    
Sub-Investigator: Paul Crawford, M.D.            
Principal Investigator: David Moss, M.D.            
Sub-Investigator: Heather Pickett, D.O.            
Sponsors and Collaborators
Mike O'Callaghan Federal Hospital
Investigators
Principal Investigator: David Moss, M.D. Mike O'Callaghan Federal Hospital/Nellis Air Force Base
  More Information

No publications provided

Responsible Party: Mike O'Callaghan Federal Hospital
ClinicalTrials.gov Identifier: NCT01302769     History of Changes
Other Study ID Numbers: FWH20110008H
Study First Received: February 18, 2011
Last Updated: April 19, 2012
Health Authority: United States: Federal Government

Keywords provided by Mike O'Callaghan Federal Hospital:
Acute Sore Throat
Ear Acupuncture

Additional relevant MeSH terms:
Pharyngitis
Pharyngeal Diseases
Stomatognathic Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on May 23, 2013